The clinical performance is complex and often involves multi-systemic burden. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching the needs of a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. The individualized development of treatment programs for the treatment and management of PML is usually comprised of drug therapy, rehabilitation interventions, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for effectiveness and adverse reactions, adjusted in a timely manner according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the treatment of PML accompanied syphilis. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.